Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1120 | 1128 | 1254 | 755 | 1188 | - |
Fund Return | 11.98% | 12.77% | 25.36% | -8.95% | 3.51% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
E Hang Seng China Enterpr ETFUSD TT | 270.02M | 10.92 | -9.88 | -3.93 | ||
E Hang Seng China Enterprise Cash | 270.02M | 10.92 | -9.88 | -3.93 | ||
E Fd S&P Info Tech Idx QDII LOF USD | 168.52M | 22.58 | 13.47 | - | ||
E Fund Global Medical Industry USD | 140.23M | -17.15 | -28.64 | - | ||
E Fd S&P 500 Idx QDII LOFUSD | 79.84M | 16.99 | 7.39 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Hwabao WP SP OilGas EP QDII LOF USD | 625.07M | 1.88 | 20.05 | - | ||
Harvest Glbl Internet Eq USD Cash Q | 179.5M | -6.29 | -7.27 | - | ||
Harvest Glbl Internet Eq USD Exch | 179.5M | -6.29 | -7.27 | - | ||
E Fd S&P Info Tech Idx QDII LOF USD | 168.52M | 22.58 | 13.47 | - | ||
Fortune SG SP US Cosmt Eq QDIILOF | 68.82M | 3.69 | 0.46 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sarepta | US8036071004 | 3.11 | 125.34 | -2.38% | |
United Therapeutics | US91307C1027 | 2.80 | 341.11 | -1.47% | |
Alnylam | US02043Q1076 | 2.69 | 261.73 | -0.07% | |
Gilead | US3755581036 | 2.67 | 83.16 | +2.74% | |
Amgen | US0311621009 | 2.65 | 330.06 | +0.02% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Sell | Strong Buy | Strong Buy |
Summary | Neutral | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review